Table 3 Treatment and outcomes in eyes with LACNP
| Â | Number (percentage) |
|---|---|
Laser burns in PRP | 1798.0 ± 724.9 |
Macular grid laser | 5 (11.6%) |
Follow-up duration (months) | 12.4 ± 16.7 |
logMAR BCVA | |
 Improved | 12 (27.9%) |
 Stable | 7 (16.3%) |
 Deteriorated | 24 (55.8%) |
Complications | |
 VH | 12 (27.9%) |
 TRD | 6 (14.0%) |
 NVG | 9 (20.9%) |
Intervention | |
 Anti-VEGF agents | 17 (39.5%) |
 PPV surgery | 11 (25.6%) |
 Anti-glaucoma surgery | 4 (9.3%) |